EQRx, Inc. (EQRX): Price and Financial Metrics


EQRx, Inc. (EQRX): $2.40

-0.10 (-4.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add EQRX to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

EQRX Stock Price Chart Interactive Chart >

Price chart for EQRX

EQRX Price/Volume Stats

Current price $2.40 52-week high $6.05
Prev. close $2.50 52-week low $1.87
Day low $2.40 Volume 1,622,611
Day high $2.52 Avg. volume 3,504,096
50-day MA $2.64 Dividend yield N/A
200-day MA $4.25 Market Cap 1.17B

EQRx, Inc. (EQRX) Company Bio


EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EGFR-mutated non-small cell lung cancer (NSCLC); and Sugemalimab, an anti-programmed death-ligand 1 antibody for the treatment of Stage III and Stage IV NSCLC. Its other programs in pipeline include clinical and pre-clinical stage assets, which comprise Lerociclib, a small molecule cyclin-dependent kinase 4/6 inhibitor, which is in Phase I clinical trials in patients with metastatic breast cancer; EQ176, an anti-programmed death-1 antibody that is in Phase III trials for the treatment of patients with primary liver cancer; and EQ121, a selective janus kinase-1 inhibitor that is in various Phase I trials. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.


EQRX Latest News Stream


Event/Time News Detail
Loading, please wait...

EQRX Latest Social Stream


Loading social stream, please wait...

View Full EQRX Social Stream

Latest EQRX News From Around the Web

Below are the latest news stories about EQRX INC that investors may wish to consider to help them evaluate EQRX as an investment opportunity.

EQRx Inc. (NASDAQ: EQRX) Stock: More Upside Ahead?

In the last trading session, 1.55 million EQRx Inc. (NASDAQ:EQRX) shares changed hands as the company’s beta touched 0. With the company’s per share price at $2.43 changed hands at $0.09 or 3.85% during last session, the market valuation stood at $1.14B. EQRX’s last price was a discount, traded about -148.97% off its 52-week high … EQRx Inc. (NASDAQ: EQRX) Stock: More Upside Ahead? Read More »

Marketing Sentinel | January 30, 2023

EQRx Inc. (NASDAQ:EQRX) Up Almost 4.95% In One Month, Looking Good For The Long Term

In last trading session, EQRx Inc. (NASDAQ:EQRX) saw 4.27 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $2.33 trading at -$0.13 or -5.28% at ring of the bell on the day assigns it a market valuation of $1.05B. That closing price of EQRX’s stock is at … EQRx Inc. (NASDAQ:EQRX) Up Almost 4.95% In One Month, Looking Good For The Long Term Read More »

Marketing Sentinel | January 26, 2023

EQRx promised to deliver cutting-edge drugs at half the cost of rivals. A cofounder shares why the once buzzy biotech is walking away from that mission

EQRx''s Alexis Borisy told Insider that regulatory delays, caused by reliance on China-based data, had changed EQRx''s pricing strategy.

Business Insider | January 19, 2023

EQRx Inc. (NASDAQ: EQRX) Stock Has Dropped -1.75% Over The Month – Is There Room For Growth?

EQRx Inc. (NASDAQ:EQRX)’s traded shares stood at 5.42 million during the last session. At the close of trading, the stock’s price was $2.80, to imply an increase of 0.36% or $0.01 in intraday trading. The EQRX share’s 52-week high remains $7.69, putting it -174.64% down since that peak but still an impressive 33.21% since price … EQRx Inc. (NASDAQ: EQRX) Stock Has Dropped -1.75% Over The Month – Is There Room For Growth? Read More »

Marketing Sentinel | January 13, 2023

Let’s Jump Into The EQRx Inc. (NASDAQ: EQRX) Stock Forecast

In the last trading session, 2.47 million EQRx Inc. (NASDAQ:EQRX) shares changed hands as the company’s beta touched 0. With the company’s per share price at $2.71 changed hands at -$0.12 or -4.24% during last session, the market valuation stood at $1.28B. EQRX’s last price was a discount, traded about -183.76% off its 52-week high … Let’s Jump Into The EQRx Inc. (NASDAQ: EQRX) Stock Forecast Read More »

Marketing Sentinel | January 10, 2023

Read More 'EQRX' Stories Here

EQRX Price Returns

1-mo -11.44%
3-mo -38.30%
6-mo -50.21%
1-year -37.50%
3-year N/A
5-year N/A
YTD -2.44%
2022 -63.93%
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7858 seconds.